GRACE
Avatar

NSCLC - Local Therapies for Metastatic LC

By GRACE FEATURING Eric Vallieres
By GRACE FEATURING Eric Vallieres
191 views
January 30, 2019
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
18:47
Total Health

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Feat. W. Iams
30:05
Cleveland Clinic Respiratory Institute

Diagnosis and Staging of Lung Cancer in the Era of Advanced Diagnost…

Feat. F. Almeida
17:34
ecancer

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

Feat. L. Raez
40:52
Houston Methodist Hospital

Respiratory Tract, EBUS, Molecular Biomarker Testing in Non-Small Ce…

Feat. S. Roy-Chowdhuri
07:38
GRACE

How Does PD-L1 Score Affect Treatment Options for NSCLC

Feat. S. Patel, T. Leal, P. Iyengar, A. Desai, C. Kim, J. Rotow
20:28
OncoAlert

mNSCLC Updates: 1L EGFRm, 2/3L EGFRm & Anti-Trop2 ADC

Feat. C. Aggarwal
10:34
GRACE

ASCO® 2023 Insights: "CheckMate 9LA 4-Year Follow-Up - Chemo + …

Feat. J. West, C. Lovly, A. Addeo
07:13
Insights from 2023 WCLC

WCLC 2023 Insights: "5-Year Survival of Pembro + Chemo for mNSC…

Feat. S. Gadgeel
13:01
Nebraska Oncology Society

ASCO 2022 on Immunotherapy Updates in Advanced NSCLC

Feat. J. Brahmer
12:26
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

2024 Neuro-Oncology Update: NSCLC and Brain Mets

Feat. T. McGranahan
06:53
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "RAMOSE Trial - Osimertinib+/-Ramucirumab i…

Feat. X. Le
14:57
ATS 2023 Insights

ATS 2023 Insights: Climate Change and Cancer

Feat. J. Schiller
18:14
Janakiraman Subramanian

Understanding KRAS G12C Positive Lung Cancer

10:29
NYU Langone

FDA Approval of Adagrasib in KRAS G12Cm NSCLC

Feat. J. Sabari
12:16
ecancer

ASCO® 2023 Summary: "Analysis of Key Studies in Lung Cancer - A…

Feat. L. Raez
33:37
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Fred Hutchinson Cancer Center Review of Metastatic NSCLC

Feat. C. Baik
04:14
ecancer

ASCO® 2023 Insights: "Phase 3 LUNAR Study - Tumor Treating Fiel…

Feat. T. Leal
14:26
Memorial Sloan Kettering Cancer Center

Radiation for Unresectable NSCLC: Where Are We Now and Where Are We …

Feat. D. Gomez
21:35
Total Health

Management of Advanced NSCLC: IO, Targeted Therapy, and Beyond

Feat. T. Patil
14:33
ILCC 2022 Conference Coverage

1L Single Agent Immunotherapy for mNSCLC

Feat. A. Chiang